“Cannabinoids have been demonstrated to exert neuroprotective effects on different types of neuronal insults.
Here we have addressed the therapeutic potential of the synthetic cannabinoid HU210 on photoreceptor degeneration, synaptic connectivity and functional activity of the retina in the transgenic P23H rat, an animal model for autosomal dominant retinitis pigmentosa (RP)…
These data suggest that cannabinoids are potentially useful to delay retinal degeneration in RP patients.”